YARW Yarrow Bioscience, Inc.
$27.01▼ -5.03%
Healthcare
Other
After hours
$27.01▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.36M
Avg Volume (10D) 41.3K
Key Metrics & Fundamentals
Market Cap
$72.11M
P/E Ratio
–
Div Yield
–%
52W Range
14.70 - 46.95
% vs 50 MA
-21.39%
% vs 200 MA
-8.39%
RSI-14
32.8
MACD Histogram
-1.0700
Beta (1Y vs SPY)
0.28
Free Cash Flow
$67.57M
Gross Rev
$97,000
Gross Profit
$97,000
EBITDA
-$3.10M
COGS
–
Operating Exp
$3.20M
Operating Income
-$3.10M
EBIT
-$3.10M
Pretax Income
-$2.90M
Net Income
-$3.01M
EPS (Diluted)
-175.50
Price & Volume History
Loading chart…
Recent News
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
Business Wire · Sep 11, 2026 1:11 AM
Yarrow Bioscience Launches Public Offering of Common Stock
MT Newswires · Sep 10, 2026 8:31 PM
Yarrow Bioscience Announces Proposed Underwritten Public Offering
Business Wire · Sep 10, 2026 8:03 PM
Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Wire · Aug 13, 2026 11:00 AM
Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease
Business Wire · Jul 27, 2026 11:00 AM
VYNE Approves 1-for-50 Reverse Stock Split
MT Newswires · Jul 21, 2026 12:37 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See YARW's money flow as a full page
Social Sentiment
No Reddit posts found for YARW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.